Acute sinusitis, also called?acute rhinosinusitis, is a short-term inflammation of the membranes that line your nose and surrounding?sinuses.
This report aims to provide a comprehensive presentation of the global market for Acute Sinusitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Sinusitis. This report contains market size and forecasts of Acute Sinusitis in global, including the following market information:
Global Acute Sinusitis Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Acute Sinusitis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
OTC Pain Relievers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Sinusitis include Teva Pharmaceutical, Sun Pharmaceutical, Sanofi, Pfizer, Novartis, Merck, Johnson & Johnson, Fresenius Kabi and Eli Lilly and Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Sinusitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Sinusitis Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Acute Sinusitis Market Segment Percentages, by Type, 2022 (%)
OTC Pain Relievers
Saline Nasal Spray
Nasal Corticosteroids
Others
Global Acute Sinusitis Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Acute Sinusitis Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Acute Sinusitis Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Acute Sinusitis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Sinusitis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acute Sinusitis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical
Sun Pharmaceutical
Sanofi
Pfizer
Novartis
Merck
Johnson & Johnson
Fresenius Kabi
Eli Lilly and Company
Dr. Reddy's Laboratories
Bristol-Myers Squibb
Bionorica
Bayer
AstraZeneca
Amgen
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Sinusitis, market overview.
Chapter 2: Global Acute Sinusitis market size in revenue.
Chapter 3: Detailed analysis of Acute Sinusitis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Sinusitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Sinusitis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Sinusitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Sinusitis Overall Market Size
2.1 Global Acute Sinusitis Market Size: 2022 VS 2030
2.2 Global Acute Sinusitis Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Sinusitis Players in Global Market
3.2 Top Global Acute Sinusitis Companies Ranked by Revenue
3.3 Global Acute Sinusitis Revenue by Companies
3.4 Top 3 and Top 5 Acute Sinusitis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Sinusitis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Sinusitis Players in Global Market
3.6.1 List of Global Tier 1 Acute Sinusitis Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Sinusitis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Sinusitis Market Size Markets, 2022 & 2030
4.1.2 OTC Pain Relievers
4.1.3 Saline Nasal Spray
4.1.4 Nasal Corticosteroids
4.1.5 Others
4.2 By Type - Global Acute Sinusitis Revenue & Forecasts
4.2.1 By Type - Global Acute Sinusitis Revenue, 2018-2023
4.2.2 By Type - Global Acute Sinusitis Revenue, 2024-2030
4.2.3 By Type - Global Acute Sinusitis Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Sinusitis Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Acute Sinusitis Revenue & Forecasts
5.2.1 By Application - Global Acute Sinusitis Revenue, 2018-2023
5.2.2 By Application - Global Acute Sinusitis Revenue, 2024-2030
5.2.3 By Application - Global Acute Sinusitis Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Acute Sinusitis Market Size, 2022 & 2030
6.2 By Region - Global Acute Sinusitis Revenue & Forecasts
6.2.1 By Region - Global Acute Sinusitis Revenue, 2018-2023
6.2.2 By Region - Global Acute Sinusitis Revenue, 2024-2030
6.2.3 By Region - Global Acute Sinusitis Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Acute Sinusitis Revenue, 2018-2030
6.3.2 US Acute Sinusitis Market Size, 2018-2030
6.3.3 Canada Acute Sinusitis Market Size, 2018-2030
6.3.4 Mexico Acute Sinusitis Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Acute Sinusitis Revenue, 2018-2030
6.4.2 Germany Acute Sinusitis Market Size, 2018-2030
6.4.3 France Acute Sinusitis Market Size, 2018-2030
6.4.4 U.K. Acute Sinusitis Market Size, 2018-2030
6.4.5 Italy Acute Sinusitis Market Size, 2018-2030
6.4.6 Russia Acute Sinusitis Market Size, 2018-2030
6.4.7 Nordic Countries Acute Sinusitis Market Size, 2018-2030
6.4.8 Benelux Acute Sinusitis Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Acute Sinusitis Revenue, 2018-2030
6.5.2 China Acute Sinusitis Market Size, 2018-2030
6.5.3 Japan Acute Sinusitis Market Size, 2018-2030
6.5.4 South Korea Acute Sinusitis Market Size, 2018-2030
6.5.5 Southeast Asia Acute Sinusitis Market Size, 2018-2030
6.5.6 India Acute Sinusitis Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Acute Sinusitis Revenue, 2018-2030
6.6.2 Brazil Acute Sinusitis Market Size, 2018-2030
6.6.3 Argentina Acute Sinusitis Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Sinusitis Revenue, 2018-2030
6.7.2 Turkey Acute Sinusitis Market Size, 2018-2030
6.7.3 Israel Acute Sinusitis Market Size, 2018-2030
6.7.4 Saudi Arabia Acute Sinusitis Market Size, 2018-2030
6.7.5 UAE Acute Sinusitis Market Size, 2018-2030
7 Acute Sinusitis Companies Profiles
7.1 Teva Pharmaceutical
7.1.1 Teva Pharmaceutical Company Summary
7.1.2 Teva Pharmaceutical Business Overview
7.1.3 Teva Pharmaceutical Acute Sinusitis Major Product Offerings
7.1.4 Teva Pharmaceutical Acute Sinusitis Revenue in Global Market (2018-2023)
7.1.5 Teva Pharmaceutical Key News & Latest Developments
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Company Summary
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Acute Sinusitis Major Product Offerings
7.2.4 Sun Pharmaceutical Acute Sinusitis Revenue in Global Market (2018-2023)
7.2.5 Sun Pharmaceutical Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Acute Sinusitis Major Product Offerings
7.3.4 Sanofi Acute Sinusitis Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Acute Sinusitis Major Product Offerings
7.4.4 Pfizer Acute Sinusitis Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Acute Sinusitis Major Product Offerings
7.5.4 Novartis Acute Sinusitis Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Acute Sinusitis Major Product Offerings
7.6.4 Merck Acute Sinusitis Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Acute Sinusitis Major Product Offerings
7.7.4 Johnson & Johnson Acute Sinusitis Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Fresenius Kabi
7.8.1 Fresenius Kabi Company Summary
7.8.2 Fresenius Kabi Business Overview
7.8.3 Fresenius Kabi Acute Sinusitis Major Product Offerings
7.8.4 Fresenius Kabi Acute Sinusitis Revenue in Global Market (2018-2023)
7.8.5 Fresenius Kabi Key News & Latest Developments
7.9 Eli Lilly and Company
7.9.1 Eli Lilly and Company Company Summary
7.9.2 Eli Lilly and Company Business Overview
7.9.3 Eli Lilly and Company Acute Sinusitis Major Product Offerings
7.9.4 Eli Lilly and Company Acute Sinusitis Revenue in Global Market (2018-2023)
7.9.5 Eli Lilly and Company Key News & Latest Developments
7.10 Dr. Reddy's Laboratories
7.10.1 Dr. Reddy's Laboratories Company Summary
7.10.2 Dr. Reddy's Laboratories Business Overview
7.10.3 Dr. Reddy's Laboratories Acute Sinusitis Major Product Offerings
7.10.4 Dr. Reddy's Laboratories Acute Sinusitis Revenue in Global Market (2018-2023)
7.10.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Company Summary
7.11.2 Bristol-Myers Squibb Business Overview
7.11.3 Bristol-Myers Squibb Acute Sinusitis Major Product Offerings
7.11.4 Bristol-Myers Squibb Acute Sinusitis Revenue in Global Market (2018-2023)
7.11.5 Bristol-Myers Squibb Key News & Latest Developments
7.12 Bionorica
7.12.1 Bionorica Company Summary
7.12.2 Bionorica Business Overview
7.12.3 Bionorica Acute Sinusitis Major Product Offerings
7.12.4 Bionorica Acute Sinusitis Revenue in Global Market (2018-2023)
7.12.5 Bionorica Key News & Latest Developments
7.13 Bayer
7.13.1 Bayer Company Summary
7.13.2 Bayer Business Overview
7.13.3 Bayer Acute Sinusitis Major Product Offerings
7.13.4 Bayer Acute Sinusitis Revenue in Global Market (2018-2023)
7.13.5 Bayer Key News & Latest Developments
7.14 AstraZeneca
7.14.1 AstraZeneca Company Summary
7.14.2 AstraZeneca Business Overview
7.14.3 AstraZeneca Acute Sinusitis Major Product Offerings
7.14.4 AstraZeneca Acute Sinusitis Revenue in Global Market (2018-2023)
7.14.5 AstraZeneca Key News & Latest Developments
7.15 Amgen
7.15.1 Amgen Company Summary
7.15.2 Amgen Business Overview
7.15.3 Amgen Acute Sinusitis Major Product Offerings
7.15.4 Amgen Acute Sinusitis Revenue in Global Market (2018-2023)
7.15.5 Amgen Key News & Latest Developments
7.16 Abbott
7.16.1 Abbott Company Summary
7.16.2 Abbott Business Overview
7.16.3 Abbott Acute Sinusitis Major Product Offerings
7.16.4 Abbott Acute Sinusitis Revenue in Global Market (2018-2023)
7.16.5 Abbott Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Acute Sinusitis Market Opportunities & Trends in Global Market
Table 2. Acute Sinusitis Market Drivers in Global Market
Table 3. Acute Sinusitis Market Restraints in Global Market
Table 4. Key Players of Acute Sinusitis in Global Market
Table 5. Top Acute Sinusitis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Sinusitis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Sinusitis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Sinusitis Product Type
Table 9. List of Global Tier 1 Acute Sinusitis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Sinusitis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Sinusitis Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Acute Sinusitis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Sinusitis Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Acute Sinusitis Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Acute Sinusitis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Sinusitis Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Acute Sinusitis Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Acute Sinusitis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Sinusitis Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Acute Sinusitis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Sinusitis Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Acute Sinusitis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Sinusitis Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Acute Sinusitis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Sinusitis Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Acute Sinusitis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Sinusitis Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Acute Sinusitis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Sinusitis Revenue, (US$, Mn), 2024-2030
Table 30. Teva Pharmaceutical Company Summary
Table 31. Teva Pharmaceutical Acute Sinusitis Product Offerings
Table 32. Teva Pharmaceutical Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 33. Teva Pharmaceutical Key News & Latest Developments
Table 34. Sun Pharmaceutical Company Summary
Table 35. Sun Pharmaceutical Acute Sinusitis Product Offerings
Table 36. Sun Pharmaceutical Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 37. Sun Pharmaceutical Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Acute Sinusitis Product Offerings
Table 40. Sanofi Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Acute Sinusitis Product Offerings
Table 44. Pfizer Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Acute Sinusitis Product Offerings
Table 48. Novartis Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Acute Sinusitis Product Offerings
Table 52. Merck Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Acute Sinusitis Product Offerings
Table 56. Johnson & Johnson Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Fresenius Kabi Company Summary
Table 59. Fresenius Kabi Acute Sinusitis Product Offerings
Table 60. Fresenius Kabi Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 61. Fresenius Kabi Key News & Latest Developments
Table 62. Eli Lilly and Company Company Summary
Table 63. Eli Lilly and Company Acute Sinusitis Product Offerings
Table 64. Eli Lilly and Company Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 65. Eli Lilly and Company Key News & Latest Developments
Table 66. Dr. Reddy's Laboratories Company Summary
Table 67. Dr. Reddy's Laboratories Acute Sinusitis Product Offerings
Table 68. Dr. Reddy's Laboratories Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 69. Dr. Reddy's Laboratories Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Summary
Table 71. Bristol-Myers Squibb Acute Sinusitis Product Offerings
Table 72. Bristol-Myers Squibb Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 73. Bristol-Myers Squibb Key News & Latest Developments
Table 74. Bionorica Company Summary
Table 75. Bionorica Acute Sinusitis Product Offerings
Table 76. Bionorica Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 77. Bionorica Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Acute Sinusitis Product Offerings
Table 80. Bayer Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 81. Bayer Key News & Latest Developments
Table 82. AstraZeneca Company Summary
Table 83. AstraZeneca Acute Sinusitis Product Offerings
Table 84. AstraZeneca Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 85. AstraZeneca Key News & Latest Developments
Table 86. Amgen Company Summary
Table 87. Amgen Acute Sinusitis Product Offerings
Table 88. Amgen Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 89. Amgen Key News & Latest Developments
Table 90. Abbott Company Summary
Table 91. Abbott Acute Sinusitis Product Offerings
Table 92. Abbott Acute Sinusitis Revenue (US$, Mn) & (2018-2023)
Table 93. Abbott Key News & Latest Developments
List of Figures
Figure 1. Acute Sinusitis Segment by Type in 2022
Figure 2. Acute Sinusitis Segment by Application in 2022
Figure 3. Global Acute Sinusitis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Sinusitis Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Acute Sinusitis Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Sinusitis Revenue in 2022
Figure 8. By Type - Global Acute Sinusitis Revenue Market Share, 2018-2030
Figure 9. By Application - Global Acute Sinusitis Revenue Market Share, 2018-2030
Figure 10. By Type - Global Acute Sinusitis Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Acute Sinusitis Revenue Market Share, 2018-2030
Figure 12. By Application - Global Acute Sinusitis Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Acute Sinusitis Revenue Market Share, 2018-2030
Figure 14. By Region - Global Acute Sinusitis Revenue Market Share, 2018-2030
Figure 15. By Country - North America Acute Sinusitis Revenue Market Share, 2018-2030
Figure 16. US Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Acute Sinusitis Revenue Market Share, 2018-2030
Figure 20. Germany Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 21. France Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Acute Sinusitis Revenue Market Share, 2018-2030
Figure 28. China Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 32. India Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Acute Sinusitis Revenue Market Share, 2018-2030
Figure 34. Brazil Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Acute Sinusitis Revenue Market Share, 2018-2030
Figure 37. Turkey Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Acute Sinusitis Revenue, (US$, Mn), 2018-2030
Figure 41. Teva Pharmaceutical Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sun Pharmaceutical Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Fresenius Kabi Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Eli Lilly and Company Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dr. Reddy's Laboratories Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bristol-Myers Squibb Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bionorica Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bayer Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. AstraZeneca Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Amgen Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Abbott Acute Sinusitis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
